Rheumatoid arthritis in Dubai—delayed diagnosis and low usage of disease modifying antirheumatic drugs
AUTOR(ES)
Badsha, Humeira
FONTE
BMJ Group
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1954679Documentos Relacionados
- Survival analysis of disease modifying antirheumatic drugs in Spanish rheumatoid arthritis patients.
- Adalimumab alone and in combination with disease‐modifying antirheumatic drugs for the treatment of rheumatoid arthritis in clinical practice: the Research in Active Rheumatoid Arthritis (ReAct) trial
- Evidence for early disease-modifying drugs in rheumatoid arthritis
- Step‐up combination versus switching of non‐biological disease‐modifying antirheumatic drugs in rheumatoid arthritis: results from a retrospective observational study
- Urinary glucaric acid excretion in rheumatoid arthritis: influence of disease activity and disease modifying drugs.